VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 49 of Oncotarget features Figure 4, "Effects of BET inhibition and its potentiation by HDAC inhibition are mediated in part by induction of apoptosis by caspase 3/7," by Kim, et al.
|
|
Table of Contents
Research Papers
|
| Geneenvironment interactions and predictors of breast cancer in familybased multiethnic groups |
|
https://doi.org/10.18632/oncotarget.25520
|
| 29019-29035 |
|
| The immunerelated microRNA miR146b is upregulated in glioblastoma recurrence |
|
https://doi.org/10.18632/oncotarget.25528
|
| 29036-29046 |
|
| Oral inflammation promotes oral squamous cell carcinoma invasion |
|
https://doi.org/10.18632/oncotarget.25540
|
| 29047-29063 |
|
| A multiomics analysis of S100 protein family in breast cancer |
|
https://doi.org/10.18632/oncotarget.25561
|
| 29064-29081 |
|
| An evaluation in vitro of the efficacy of nutlin3 and topotecan in combination with 177LuDOTATATE for the treatment of neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25607
|
| 29082-29096 |
|
| InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment |
|
https://doi.org/10.18632/oncotarget.25624
|
| 29097-29111 |
|
| Resveratrol prevents p53 aggregation in vitro and in breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25631
|
| 29112-29122 |
|
| Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes |
|
https://doi.org/10.18632/oncotarget.25632
|
| 29123-29139 |
|
| PARP1Erk synergism in proliferating cells |
|
https://doi.org/10.18632/oncotarget.25633
|
| 29140-29145 |
|
| Regulation of the interferongamma IFNγ pathway by p63 and Δ133p53 isoform in different breast cancer subtypes |
|
https://doi.org/10.18632/oncotarget.25635
|
| 29146-29161 |
|
| Collaborating genomic transcriptomic and microbiomic alterations lead to canine extreme intestinal polyposis |
|
https://doi.org/10.18632/oncotarget.25646
|
| 29162-29179 |
|
| Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas |
|
https://doi.org/10.18632/oncotarget.25650
|
| 29180-29192 |
|
| BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition |
|
https://doi.org/10.18632/oncotarget.25670
|
| 29193-29207 |
|
| Circular RNA CpG island hypermethylationassociated silencing in human cancer |
|
https://doi.org/10.18632/oncotarget.25673
|
| 29208-29219 |
|
| Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25678
|
| 29220-29232 |
Clinical Research Papers
|
| Evaluation of modified carbapenem inactivation method for suspected carbapenemase among Enterobacteriaceae clinical isolates |
|
https://doi.org/10.18632/oncotarget.25603
|
| 29233-29237 |
Reviews
|
| Pharmacogenetic studies with oral anticoagulants Genomewide association studies in vitamin K antagonist and direct oral anticoagulants |
|
https://doi.org/10.18632/oncotarget.25579
|
| 29238-29258 |
|
| Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy |
|
https://doi.org/10.18632/oncotarget.25660
|
| 29259-29274 |
Case Reports
|
| Papillary thyroid microcarcinoma Black Ink |
|
https://doi.org/10.18632/oncotarget.25621
|
| 29275-29283 |
Corrections
|
| Correction: Resistance to anticancer vaccination effect is controlled by a cancer cellautonomous phenotype that disrupts immunogenic phagocytic removal |
|
https://doi.org/10.18632/oncotarget.25721
|
| 29284-29284 |
|
| Correction: Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies |
|
https://doi.org/10.18632/oncotarget.25726
|
| 29285-29285 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
